As of 17 Sept 2026, Zydus Lifesciences Ltd share price is ₹1,111.30. The stock opened at ₹1,111.30 and had closed at ₹1,105.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹835.85 and a high of ₹1,205.65. In terms of performance, Zydus Lifesciences Ltd share price has increased by 22.95% over the past six months and has increased by 5.45% over the last year.
ZYDUSLIFE Stock Price Chart
Zydus Lifesciences Ltd Overview
About ZYDUSLIFE
Zydus Lifesciences operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.(Source : 202503-Annual Report Page No:291)
Zydus Lifesciences Ltd Historical Performance
ZYDUSLIFE Futures & Options
Zydus Lifesciences Ltd Fundamentals
Zydus Lifesciences Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 13,151.50 | 15,812.50 | 11,903.50 | 9,280.00 | 8,015.60 |
| EBITDA | 5,426.00 | 8,432.50 | 5,134.90 | 2,799.00 | 1,777.50 |
| Net Profit | 3,559.80 | 5,774.90 | 3,441.50 | 1,529.20 | 857.90 |
| EPS | 35.38 | 57.39 | 34.01 | 15.06 | 8.38 |
Zydus Lifesciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,089.95 |
| Resistance 1 (R1) | 1,116.10 |
| Pivot Point | 1,101.05 |
Zydus Lifesciences Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 24-Jul-2026 | 19-May-2026 | 24-Jul-2026 | Final | ₹1.00 |
| 25-Jul-2025 | 19-May-2025 | 25-Jul-2025 | Final | ₹11.00 |
| 26-Jul-2024 | 17-May-2024 | 26-Jul-2024 | Final | ₹3.00 |
| 28-Jul-2023 | 18-May-2023 | 28-Jul-2023 | Final | ₹6.00 |
| 28-Jul-2022 | 20-May-2022 | 29-Jul-2022 | Final | ₹2.50 |
ZYDUSLIFE Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Pankaj R Patel | Chairman |
| Sharvil P Patel | Managing Director |
| Ganesh N Nayak | Executive Directorector |
Zydus Lifesciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,853.90+0.02% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,260.50+1.12% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,805.50-0.15% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Zydus Lifesciences Ltd today is ₹1,111.30 on NSE and ₹1,111.30 on BSE.
- The 52-week high of Zydus Lifesciences Ltd is ₹1,205.65, while the 52-week low is ₹835.85.
- The current market capitalisation of Zydus Lifesciences Ltd is approximately ₹1,10,224 crore.
- The P/E (Price-to-Earnings) ratio of Zydus Lifesciences Ltd is 17.95. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Zydus Lifesciences Ltd is 3.57. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Zydus Lifesciences Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ZYDUSLIFE on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Zydus Lifesciences Ltd has delivered a return of approximately 71.15%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Zydus Lifesciences Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 75.01% promoters, 1.77% FIIs, 11.27% DIIs, and 5.45% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
